NCT00615069View on ClinicalTrials.gov

Study of the Large Diameter GORE EXCLUDER® AAA Endoprosthesis in Abdominal Aneurysms

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

March 31, 2008

Study Completion Date

June 30, 2014

Conditions
Aortic Aneurysm, Abdominal
Interventions
DEVICE

31 mm GORE EXCLUDER® AAA Endoprosthesis

GORE EXCLUDER® AAA Endoprosthesis - 31 mm device implanted for the primary treatment of infrarenal abdominal aortic aneurysms (AAA)

Trial Locations (1)

59101

St. Vincent Healthcare, Billings

All Listed Sponsors
lead

W.L.Gore & Associates

INDUSTRY

NCT00615069 - Study of the Large Diameter GORE EXCLUDER® AAA Endoprosthesis in Abdominal Aneurysms | Biotech Hunter | Biotech Hunter